Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.76M | $0.00 | -$30.62M | -$35.84M | -$5.66 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $18.42M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $34.36M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $59.29M | $242.00k | -$38.02M | -$38.06M | -$2.36 | N/A | N/A | N/A | N/A | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $387.44M | $0.00 | -$227.85M | -$240.91M | -$2.25 | N/A | N/A | N/A | N/A | 2026-03-02 | ||
| SGMO | SANGAMO THERAPEUTICS INC | $122.48M | $32.88M | -$101.50M | -$108.91M | -$0.45 | -37.13% | -25.91% | N/A | N/A | 2026-02-25 | ||
| SKYE | SKYE BIOSCIENCE INC | $32.38M | $0.00 | -$50.55M | -$51.23M | -$1.29 | N/A | N/A | N/A | N/A | |||
| TLRY | TILRAY BRANDS INC | $914.58M | $837.32M | -$2.11B | -$2.11B | -$23.11 | 0.98% | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $50.00M | $0.00 | -$18.04M | -$20.26M | -$0.82 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $34.33M | $2.06M | -$17.01M | -$19.80M | -$0.72 | 63.53% | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $170.22M | $1.98M | -$89.61M | -$90.49M | -$1.11 | -31.13% | N/A | N/A | N/A | 2026-02-13 | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.94M | $0.00 | -$14.51M | -$12.70M | -$0.55 | N/A | N/A | N/A | N/A | 2026-02-25 | ||
| SLN | SILENCE THERAPEUTICS PLC | $236.41M | $26.10M | -$67.75M | -$66.59M | N/A | 27.31% | N/A | N/A | N/A | 2026-03-18 | ||
| IFRX | INFLARX NV | $61.72M | $73.07k | -$46.08M | -$46.63M | -$0.70 | -60.51% | N/A | N/A | N/A | 2026-03-19 | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $33.71M | $0.00 | -$22.71M | -$22.76M | -$0.46 | N/A | N/A | N/A | N/A | 2026-03-23 | ||
| ACET | ADICET BIO INC | $80.94M | $0.00 | -$105.29M | -$115.01M | -$20.00 | N/A | -100.00% | N/A | N/A | 2026-03-05 | ||
| IMUX | IMMUNIC INC | $73.25M | $0.00 | -$102.73M | -$103.05M | -$0.83 | N/A | N/A | N/A | N/A | 2026-02-19 | ||
| SNTI | SENTI BIOSCIENCES INC | $27.08M | $0.00 | -$43.38M | -$47.58M | -$3.28 | N/A | N/A | N/A | N/A | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $44.47M | $0.00 | -$32.21M | -$34.88M | -$0.82 | N/A | N/A | N/A | N/A | 2026-03-26 | ||
| ATYR | ATYR PHARMA INC | $66.04M | $190.00k | -$73.96M | -$75.12M | -$0.82 | -19.15% | -53.29% | N/A | N/A | 2026-03-12 | ||
| TVRD | TVARDI THERAPEUTICS INC | $38.09M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | 2026-03-11 | ||
| SLE | SUPER LEAGUE ENTERPRISE INC | $5.66M | $11.57M | -$10.72M | -$15.86M | -$303.00 | -48.05% | 49.54% | N/A | N/A | 2026-03-26 | ||
| PALI | PALISADE BIO INC | $248.84M | $0.00 | -$11.10M | -$11.23M | -$2.12 | N/A | -100.00% | N/A | N/A | |||
| MYO | MYOMO INC | $33.17M | $41.64M | -$9.73M | -$12.02M | -$0.28 | 64.99% | 50.95% | N/A | N/A | 2026-03-16 | ||
| VERU | VERU INC | $41.73M | $0.00 | -$22.57M | -$22.73M | -$1.55 | N/A | -100.00% | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $31.93M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | |||
| HUMA | HUMACYTE INC | $187.27M | $1.57M | -$18.88M | -$36.97M | -$0.23 | N/A | N/A | N/A | N/A | 2026-03-26 | ||
| TNYA | TENAYA THERAPEUTICS INC | $109.89M | $0.00 | -$82.99M | -$94.26M | -$0.77 | N/A | N/A | N/A | N/A | 2026-03-24 | ||
| ZSPC | ZSPACE INC | $14.44M | $31.55M | -$20.08M | -$21.79M | -$135.53 | -24.20% | N/A | N/A | N/A | 2026-03-26 | ||
| CTSO | CYTOSORBENTS CORP | $42.90M | $34.35M | -$8.52M | -$10.59M | -$0.18 | 15.09% | -1.19% | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $162.83M | $1.20M | -$21.76M | -$28.32M | -$0.79 | N/A | N/A | N/A | N/A | |||
| ONCY | ONCOLYTICS BIOTECH INC | $115.04M | $0.00 | -$25.02M | -$25.19M | -$0.28 | N/A | N/A | N/A | N/A | 2026-03-05 | ||
| IOBT | IO BIOTECH INC | $22.30M | $0.00 | -$87.26M | -$88.35M | -$1.35 | N/A | N/A | N/A | N/A | 2026-03-04 | ||
| JSPR | JASPER THERAPEUTICS INC | $44.49M | $0.00 | -$89.05M | -$91.02M | -$5.92 | N/A | N/A | N/A | N/A | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $71.45M | $500.00k | -$42.09M | -$41.57M | -$0.30 | -50.00% | N/A | N/A | N/A | |||
| CLNN | CLENE INC | $50.74M | $214.00k | -$25.96M | -$30.50M | -$3.39 | -49.17% | 3.87% | N/A | N/A | |||
| HELP | CYBIN INC | $164.23M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| BMEA | BIOMEA FUSION INC | $89.09M | $0.00 | -$91.46M | -$95.71M | -$2.38 | N/A | N/A | N/A | N/A | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $34.66M | $0.00 | -$65.24M | -$72.84M | -$1.62 | -100.00% | N/A | N/A | N/A | 2026-03-19 | ||
| INTZ | INTRUSION INC | $22.92M | $7.29M | -$6.25M | -$8.19M | -$0.45 | 33.49% | -0.86% | N/A | N/A | |||
| CING | CINGULATE INC | $39.93M | $0.00 | -$21.49M | -$22.06M | -$3.62 | N/A | N/A | N/A | N/A | |||
| MGX | METAGENOMI INC | $60.07M | $30.91M | -$79.41M | -$88.74M | -$2.40 | -43.88% | N/A | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $59.64M | $0.00 | -$79.45M | -$81.75M | -$2.12 | N/A | N/A | N/A | N/A | |||
| TCRX | TSCAN THERAPEUTICS INC | $60.15M | $8.42M | -$136.89M | -$142.60M | -$1.12 | -10.03% | N/A | N/A | N/A | 2026-03-11 | ||
| CAN | CANAAN INC | $403.61M | $422.23M | N/A | -$218.13M | -$0.68 | 83.87% | 27.25% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.